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Many neuropeptides and peptide hormones require
amidation of their carboxy terminal for full biological
activity. The enzyme peptidyl-a-hydroxyglycine
a-amidating lyase (PAL; EC 4.3.2.5) catalyzes the
second and last step of this reaction, N-dealkylation
of the peptidyl-a-hydroxyglycine to generate the
a-amidated peptide and glyoxylate. Here we report
the X-ray crystal structure of the PAL catalytic core
(PALcc) alone and in complex with the nonpeptidic
substrate a-hydroxyhippuric acid. The structures
show that PAL folds as a six-bladed b-propeller.
The active site is formed by a Zn(II) ion coordinated
by three histidine residues; the substrate binds to
this site with its a-hydroxyl group coordinated to
the Zn(II) ion. The structures also reveal a tyrosine
residue (Tyr654) at the active site as the catalytic
base for hydroxyl deprotonation, an unusual role for
tyrosine. A reaction mechanism is proposed based
on this structural data and validated by biochemical
analysis of site-directed PALcc mutants.
INTRODUCTION
a-Amidation of neuropeptides and peptide hormones is a post-
translational modification in most cases essential for their full
biological activity—receptor recognition and signal transduction
(Eipper et al., 1992; Merkler, 1994; Prigge et al., 2000). Active
a-amidated peptides are produced by N-oxidative cleavage of
glycine-extended substrates generated from precursor proteins
by sequential endo- and exoproteolysis. The oxidative cleavage
is catalyzed by peptidylglycine a-amidating monooxygenase
(PAM), an enzyme localized to the trans-Golgi network and
secretory granules of neural and endocrine tissues. PAM is
a bifunctional enzyme with two domains: (1) peptidylglycine
a-hydroxylating monooxygenase (PHM; EC 1.14.17.3) and (2)
peptidyl-a-hydroxyglycine a-amidating lyase (PAL; EC 4.3.2.5).
These two domains act sequentially to generate an active a-ami-
dated peptide product and glyoxylate (Figure 1). Although PHM
and PAL are encoded by the same transcript in many species
(e.g., human, rat, and Xenopus), the domains may be encoded
by separate genes (Drosophila, Cnidaria, and Schistosomes)
(Kolhekar et al., 1997).Structure 17PHM is a dicopper, ascorbate-dependent monooxygenase
that catalyzes the stereospecific a-hydroxylation of glycine-
extended precursor peptides bymolecular oxygen (O2). The rele-
vance of PHM in physiology and medicine has been recently
highlighted by investigations in rat brain stem that have revealed
that intermittent hypoxia (associated with sleep apneas) acti-
vates PHM (Sharma et al., 2009). Also, studies on Drosophila
have shown that reduced PHM activity leads to defects in
memory retention and learning (Iliadi et al., 2008). In the mecha-
nism of PHM, the two electrons required for dioxygen reduction
are provided by ascorbate via one-electron reductions of the two
copper centers, CuM and CuH. The X-ray structure of PHM
(Prigge et al., 1997) revealed that it was organized into N- and
C-terminal domains of about 150 residues connected by a linker
peptide. Each domain contains nine b strands and binds one
copper ion. The copper centers are separated 11 A˚ by a solvent-
and substrate-accessible cleft. Subsequent studies showed that
the substrate binds close to the CuM site, where hydroxylation
takes place, while the CuH site has been identified as an electron
transfer site (Prigge et al., 1999). Kinetic investigations, kinetic
isotope effect measurements, theoretical calculations, and
structural studies point to a CuM-bound reactive oxygen species
as responsible for hydrogen-atom abstraction (Chen and
Solomon, 2004b; Crespo et al., 2006; Francisco et al., 1998;
Prigge et al., 2004).
While a large amount of data is now available for the interpre-
tation of the reaction mechanism of PHM (Chen and Solomon,
2004a; Crespo et al., 2006; Klinman, 2006), much less is known
about the PAL domain of PAM, which catalyzes the N-dealkyla-
tion of the peptidyl-a-hydroxyglycine intermediate generated by
PHM (Kolhekar et al., 2002). The PAL reaction resembles the
reaction catalyzed by ureidoglycolate lyase (UGL; EC 4.3.2.3),
which cleaves ureidoglycolate to produce urea and glyoxylate
(Trijbels and Vogels, 1966). Although PAL can function as an ure-
idoglycolate lyase (De et al., 2006), no sequence homology is
apparent between PAL and B. cepacia UGL (McIninch et al.,
2003) and the lack of structural data for UGL precludes further
comparison. Previous investigations defined the PAL catalytic
core (PALcc; residues 498–820), revealed that the protein
contains equimolar amounts of Zn(II) and Ca(II), and showed
that a conserved tyrosine residue (Tyr654) plays an essential
role in catalysis (De et al., 2006; Kolhekar et al., 2002). Both diva-
lent cations were shown to play an important role in maintaining
the stability of PAL (Kolhekar et al., 2002). At pH > 7 peptidyl-a-
hydroxyglycine substrates do not require an enzyme to form
the amidated peptide (Katopodis et al., 1991), suggesting that, 965–973, July 15, 2009 ª2009 Elsevier Ltd All rights reserved 965
Figure 1. The Sequential Stereo-Specific
Reactions of PAM Catalyzed by PHM and
PAL
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the physiological pH of secretory granules, where the N-dealky-
lation reaction takes place, is acidic (pH 5.0–6.0) (Prigge et al.,
2000). It was proposed that in the PAL-catalyzed reaction zinc
is part of the active site but it was not possible to determine
whether the metal binds to the substrate directly or whether a
zinc-water/hydroxyl group serves as the deprotonating agent.
Here we report the X-ray crystal structure of the rat (Rattus
norvegicus) PALcc alone and in complex with the nonpeptidic
substrate a-hydroxyhippuric acid (HydHipA). PAL folds as a
six-bladed b-propeller with a zinc ion at the active site coordi-
nated by three histidine residues. The previously identified
essential tyrosine (Tyr654) (De et al., 2006) and a key arginine
(Arg706) are positioned in the active site. A mechanism for the
PAL reaction with essential roles for both of these residues is
proposed and validated by biochemical analysis of PALcc
mutants. The calcium binds to three b strands in a fashion that
is consistent with its important structural role in enhancing the
stability of the protein (Kolhekar et al., 2002).
RESULTS
Structure Determination and Refinement
PALcc, consisting of residues 498–820 of rat PAM and an
N-terminal His6 tag, was expressed in stably transfected CHO
cells and purified as described in Experimental Procedures.
The protein crystallizes in the orthorhombic space group
(P212121) in the presence of equimolar amounts of Zn(II) and
Fe(III). Initial phases were determined by multiwavelength anom-
alous diffraction (MAD) of an Hg derivative. These initial phases
were used to locate the catalytic Zn2+ site using Zn MAD data
from a native crystal. Combination of the Hg and the Zn MAD
data using the program autoSHARP (Vonrhein et al., 2007) re-
sulted in a clear electron density map into which the structure
was built. Cycles of manual rebuilding and refinement gave an
R value of 20% (R-free 26%) (see Table 2). The His6 tag is
ordered in the structure, with the first two histidines coordinating
an iron(III) ion present in the mother liquor (or a mercury(II) ion
when the protein was crystallized in the presence of HgAc2
instead of ZnAc2/FeCl3). Interestingly, the His6 tag remained
ordered even when the protein was crystallized in the absence
of metal (0.1 M NaAc [pH 4.6]; 9%–12% PEG8000).
Overall Structure
PAL folds as a b-propeller, with six blades positioned around
a central cavity (central pore) (Figure 2). Each blade contains
four antiparallel b strands, with the first strand at the center of
the propeller and the last at the edge. The loops connecting
strand 4 of one blade to strand 1 of the next blade (loops 4-1)966 Structure 17, 965–973, July 15, 2009 ª2009 Elsevier Ltd All rightand the loops connecting strands 2 and 3 of each blade (loops
2-3) form the ‘‘cup’’ of the b-propeller. As in other b-propeller
enzymes, the cup encompasses the active site. Loop 2-3 of
the first blade contains 20 residues, significantly longer than
the equivalent loop in the other blades, which are 4–8 residues
long. This long first blade loop provides a tryptophan (Trp538)
that creates a hydrophobic pocket for the substrate and may
also provide a surface for interacting with the PHM domain in
the complete PAM enzyme. The N-terminal His tag starts at
the periphery of the propeller, preceding the N-terminal
sequence of PALcc that forms b strand 4 of the sixth blade.
b strands 1–3 of the sixth blade are formed by the C terminus
of PALcc, which ends just after completing b strand 3. In the
construct under study, the N-terminal His tag and the C termini
of PALcc form a ‘‘latch’’ that ties the structure together. In the
bifunctional PAM protein, the linker that joins PHMcc to PALcc
would replace this His tag (Prigge et al., 2000). In membrane-
bound PAM, PALcc is followed by a transmembrane helix that
anchors the enzyme to the membrane (Prigge et al., 2000).
This ‘‘latch’’-like arrangement of PALcc places PHMcc close to
the membrane, where PHMcc is believed to receive electron
equivalents from cytochrome b561 via regeneration of intrave-
sicular ascorbate (Iliadi et al., 2008; Kent and Fleming, 1987;
Tsubaki et al., 2005).
PAL contains four NHL repeats (581–608, 633–662, 686–714,
and 782–809). NHL repeats, first identified in NCL-1, HT2A, and
LIN-41 proteins, consist of sequences rich in glycine, proline,
hydrophobic residues, and a cluster of charged residues that
in the case of PAL are aspartates (Slack and Ruvkun, 1998).
The NHL repeats correspond to the first, second, and third
strands of blades 2, 3, 4, and 6, where they contribute to intramo-
lecular b strand-to-b strand interactions.
Figure 2. Crystal Structure of His6-PALcc
The PAL enzyme folds as a six-bladed b-propeller; the figure shows two views:
oriented with the central cavity normal to the page (left) and with the central
cavity in plane of the page (right). Four strands form each of the blades,
numbered 1–6 around the periphery. The Zn(II) and Ca(II) ions are indicated
as blue and green balls, respectively (Zn-Ca distance = 11 A˚).s reserved
Structure of the Active Site and Zinc(II) Coordination
Zinc(II) and calcium(II) are present in the PAL structure in agree-
ment with the results of inductively coupled plasma optical emis-
sion spectrometry (De et al., 2006). The zinc ion, accurately
located using anomalous scattering data collected at the Zn
absorption edge wavelength (1.28 A˚), is on the central axis of
the propeller, at the ‘‘bottom’’ of the cup (Figure 2). It is coordi-
nated by the N3 atoms of three conserved histidine residues
(His585, His690, and His786) and an acetate ion bound as a mono-
dentate ligand (Figure 3A). Proline residues (Pro584, Pro689, and
Pro785) precede each of the three histidines that coordinate the
Zn(II) ion. Since the substrate also binds at this site (see below),
it is clear that this is the catalytic site of PAL. The Zn-N3 bond
Figure 3. Metal Sites of PALcc
(A) Active site of PALcc. The zinc(II) (blue ball) ion is
in close proximity to the essential tyrosine Y654
and a key arginine, R706, and is coordinated in
a very distorted tetrahedral polyhedron liganded
by three histidines and one acetate bound in
a monodentate fashion. Relevant distances
include the following: Zn-N3H585 = 2.1 A˚; Zn-
N3H690 = 2.1 A˚; Zn-N3H786 = 2.1 A˚; Zn-O1acetate =
2.0 A˚; Zn-O2acetate = 3.3 A˚; Zn-OHY654 = 3.2 A˚.
Carbons are colored green, nitrogens blue, and
oxygens red. The gray mesh represents the
2Fo  Fc electron density contoured at 1s.
(B) Calcium site of PALcc. The calcium(II) ion
(green ball) is bound in the middle of the central
cavity by three residues that belong to three
different b strands: the carboxylate of D787 (as
a monodentate ligand) and the main-chain
carbonyl groups of V520 and L587. Three water
molecules and a glycerol complete the coordina-
tion sphere (Ca-OD787 = 2.45 A˚; Ca-OV520 = 2.5 A˚;
Ca-OL587 = 2.3 A˚; Ca-OW = 2.5 A˚; Ca-OW = 2.6 A˚;
Ca-OW = 2.7 A˚; Ca-Oglycerol = 2.75 A˚). Carbons are
colored green, nitrogens blue, and oxygens red.
The gray mesh represents the 2Fo  Fc electron
density contoured at 1s.
distances (2.1 A˚, 2.1 A˚, and 2.1 A˚;
Figure 3A) are within expected values
(Harding, 2006) but the N3-Zn2+-N3
angles (97.9, 95.0, and 103.7) are inter-
mediate between octahedral and tetra-
hedral geometries. A Zn(His)3 motif has
been found in thecatalytic site of enzymes
such as carbonic anhydrase (Krishna-
murthy et al., 2008), b-lactamase (Toney
et al., 2001), epimerase (Luo et al., 2001),
protease (Hege and Baumann, 2001),
proteinase (Maskos et al., 1998; Schla-
genhauf et al., 1998), macrophage elas-
tase (Lang et al., 2001), and aldolase
(Hall et al., 2002) and mediates dimeriza-
tion in human interferon b (Karpusas
et al., 1997).
As revealed during the Hg MAD exper-
iments, Hg(II) replaces Zn(II) at the active
site when the enzyme is exposed at 1mM
mercury(II) acetate, rendering the enzyme inactive (see Figure S1
available online). Interestingly, the activity of PAL increases in the
presence of rising concentrations of Cd(II), suggesting that Cd(II)
can replace Zn(II) andmakes the enzymemore active (Figure S1).
Calcium(II) Site
A calcium ion is present in the middle of the central pore, 11 A˚
from the zinc (Figure 2). The identity of this Ca2+ was determined
by anomalous scattering data and confirmed by its typical hep-
tacoordination and metal-ligand distances (Ca-O = 2.3–2.5 A˚)
(Harding, 2006). It is coordinated by the carboxylate group (as
monodentate ligand) of Asp787 and by main-chain carbonyls of
Val520 and Leu587 (Figure 3B). These residues belong to three
Structure
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Structure of Peptidyl-a(OH)glycine Amidating Lyasedifferent b strands, consistent with the structural role of the
calcium demonstrated before (Kolhekar et al., 2002) (see Discus-
sion below).
Tyrosine 654 and Arginine 706 at the Active Site
Tyr654, the only tyrosine residue conserved in every PAL known
to be catalytically active, has an essential role in catalysis: muta-
tion of Tyr654 to Phe results in complete elimination of enzymatic
activity (De et al., 2006). In the structure of PAL this tyrosine is
located in the active site with its OH oxygen at 3.2 A˚ from the
catalytic Zn2+ ion (Figure 3A). The adjoining residue, Cys655,
forms a disulfide bridge with Cys634, positioning the tyrosine
accurately for catalysis. Reduction of this disulfide bridge may
explain why reducing agents such as ferrocyanide, ascorbate,
and dithionite lead to inhibition of PAL (De et al., 2006). Also at
the active site, a highly conserved arginine residue (Arg706) is
located in close proximity to Tyr654, with its guanidinium group
at H bond distance (2.7 A˚) from the hydroxyl of the tyrosine
(Figure 3A); the Glu707 helps position of this arginine. As with
Tyr654, Arg706 is essential for catalysis, as revealed by site-
directed mutagenesis studies (see below).
Structure of the PAL-HydHipA Complex
To generate stable crystals of PAL in complex with its substrate,
the protein was rendered inactive by crystallizing it with Hg(II)
instead of Zn(II) in the active site (see above). The structure,
PAL crystals grown in 0.5 mM Hg(II) and then soaked in mother
liquor supplemented with the nonpeptide substrate HydHipA
(final substrate concentration of 5 mM) (Katopodis and May,
1990), was determined by molecular replacement using the
coordinates of native PALcc as the search molecule. 2Fo  Fc
(contoured at 1 s) and the Fo  Fc (contoured at 2.5 s) electron
density maps showed extra density at the active site compatible
with the presence of a complete HydHipAmolecule (Figure 4). As
expected, there was no reaction in the presence of Hg(II) and the
HydHipA was not cleaved.
The structure revealed at least three relevant interactions
between the protein and the substrate. The HydHipA carbox-
ylate interacts with the Arg533 guanidinium via a bidentate salt
bridge. This guanidinium is in turn accurately positioned through
hydrogen bonds to two adjacent residues (Gln516, 2.8 A˚; main-
chain carbonyl Pro584, 2.6 A˚). The substrate a-OH is coordinat-
ing the Hg(II) (Hg-O = 2.4 A˚) and is in close proximity to the
hydroxyl group of Tyr654 (2.4 A˚). One of the substrate carboxylate
oxygens is at 3.0 A˚ from the Hg(II) (O-Hg-His690 = 170.0; O-Hg-
His786 = 87.2). In addition, the Tyr654 hydroxyl is close to the
substrate NH (3.7 A˚), the leaving group of the PAL reaction
(Figure 4). Met784 is also part of the substrate binding site: its
sulfur atom is at 4.2 A˚ from the carbonyl group of the substrate
peptide bond, providing the only contact to the residue
preceding the hydroxylated glycine.
Model of the PAL-[Ala-Ala-Gly(OH)] Complex
A PAL-substrate complex was modeled using a (S)-a-hydroxy-
glycine tripeptide model, Ala-Ala-Gly(OH) (Figure 4C). This
peptide was manually built into the PAL active site by matching
the atoms of the hydroxyglycine moiety with the equivalent
atoms of the HydHipA, for which experimental data are available
(see above). Also, the diastereomer (R)-a-hydroxyglycine Ala-968 Structure 17, 965–973, July 15, 2009 ª2009 Elsevier Ltd All rigAla-Gly(OH) was modeled to investigate whether the structural
data reported here account for the stereospecificity exhibited
by PAL reaction (Ping et al., 1992). When the stereoisomer (R)
Figure 4. PAL-Substrate Complex
(A) PALcc-HydHipA complex structure showing the substrate bound to the
metal, Arg533 and Tyr654.
(B) A different view of the PALcc-HydHipA structure showing the substrate
also interacting with Met784.
(C) PAL tripeptide [Ala-Ala-Gly(OH)] model complex showing themost relevant
interactions, as seen in (B). See text for further discussion. Carbons are
colored gray, nitrogens blue, and oxygens red. A purple mesh represents
the calculated sigmaA weighted mFo  DFc omit map (Refmac5) of the
substrate, contoured at 2s (A and B). The dashed lines represent relevant inter-
actions between the substrate and the protein (see text).hts reserved
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only a different Ca-OH configuration, the binding mode is
nonproductive because the putative OH is not coordinated to
the Zn2+ and placed away from the catalytic Tyr654. When the
stereoisomer (R) is placed with the OH coordinated to the
Zn2+ and hydrogen bonded to the Tyr654, in an apparent produc-
tive binding, the substrate amide group and the protein Met784
collide. Thus, the Met784 appears to have a role in determining
the stereospecificity of PAL reaction.
Site-Directed Mutagenesis of PALcc
The PAL structures point to Tyr654, Arg706, Arg533, and Met784 as
residues that participate in substrate binding and may be ex-
pected to play an important role in catalysis. Consistent with
these observations, previous mutagenesis studies showed that
Tyr654 plays an essential role in catalysis (De et al., 2006). Muta-
tion of PALcc at residues Arg706, Arg533, and Met784 was studied
to determine their effect on the catalytic activity. Asp787, one of
the residues that binds Ca(II), was also mutated to determine
whether perturbation of the calcium site had any effect on PAL
activity. The ability of transiently transfected cells to secrete
mutant PALcc efficiently was taken as an indication that the
protein folded and acquired enough native structure to exit the
endoplasmic reticulum (Figure 5). Each of the PALcc mutants
examined was secreted as efficiently as wild-type PALcc.
Km and Vmax values for each PALcc mutant were determined
by varying the concentration of Ac-Tyr-Val-a-hydroxyglycine
from 1 mM to 50 mM (Table 1). Relative Vmax values were calcu-
lated by quantifying PALcc protein levels based on western
blot analysis. The relative Vmax of PALcc R706A was only 3%
that of wild-type PALcc, confirming the essential role of Arg706
in PAL catalysis. PALcc R706Q was 26% as active as wild-
type PALcc; the amide group of Gln706 interacting to Tyr654 in
a similar manner as the guanidinium of Arg706 does to Tyr654 in
the wild-type enzyme (see Discussion below) could explain the
26% activity exhibited by R706Q mutant. This activity may be
aided by Glu707 (mentioned above) that may become a potential
proton acceptor. Neither mutation of R706 had a dramatic effect
on the Km value. The relative Vmax of PALcc bearing an Arg
533
Figure 5. Site-Directed Mutagenesis Stu-
dies on PALcc
PEAK-Rapid cells were transiently transfected
with vectors encoding wild-type PALcc or each
of the mutants indicated. After 24 hr, cells were
rinsed and incubated in complete serum-free
medium (m) and cells (c) were harvested in TES-
mannitol-Triton buffer with protease inhibitors.
Samples were analyzed by western blot (0.8% of
the medium; 4% of the cell extract) using an anti-
peptide polyclonal antibody and aliquots were as-
sayed for PAL activity. The activity of each sample
is shown at the top of each gel lane.
Table 1. Kinetic Analysis of PALcc Mutants
PAL Tested Km (mM) Relative Vmax (pmol/h/OD)
PALcc 13.8 ± 2.8 1.00 ± 2.8
R533A 21.3b 0.03 ± 0.006a
R533Q 24.2b 0.02 ± 0.007a
R706A 25.5b 0.03 ± 0.006a
R706Q 15.8 ± 1.5a 0.26 ± 0.039a
M784A 95.2b 0.41 ± 0.005a
M784Q 94.6 ± 21.6a 0.39 ± 0.014a
D787A 33.4 ± 5.5a 1.19 ± 0.16
aSignificantly different from PALcc, p < 0.01.
bDetermined once.
mutation (to Ala or Gln) was reduced
about 50-fold compared to wild-type
PALcc. With so little activity, Km values
were difficult to measure, but appeared
to increase slightly; lack of an interaction
between the substrate carboxylate and Arg533 may compromise
the ability of substrate to adopt the precise orientation required
for effective catalysis. The PALcc-HydHipA structure identified
Met784 as a key part of the substrate binding site; mutation of
this residue to Ala or Gln increased Km approximately 6-fold
while reducing relative Vmax 2-fold. Asp
787 binds calcium in the
crystal structure; PALcc bearing an Asp787 to Ala mutation
showed no change in relative Vmax and a 2-fold increase in Km.
DISCUSSION
During peptide amidation, following hydroxylation of the terminal
glycine residue, the extended peptide disproportionates into the
amidated peptide and glyoxylate. This reaction, which occurs
spontaneously at neutral pH, requires the action of an enzyme,
PAL, because in vivo it takes place in the acid environment of
the secretory granules (Katopodis et al., 1991). PAL folds as
a six-blade b-propeller with extended loops at the ‘‘top’’ and
‘‘bottom’’ ends of the propeller. A Zn2+ ion is present at the top
of the propeller, coordinated by three histidine residues located
in three different b strands. A Ca2+ ion, located in the middle of
the propeller, 11 A˚ from the Zn2+, is ideally positioned to confer
additional stability to the structure, in agreement with biochem-
ical experiments showing that chelation of the Ca2+ reduces the
Structure 17, 965–973, July 15, 2009 ª2009 Elsevier Ltd All rights reserved 969
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A mechanism for PAL is proposed on the basis of
structural and biochemical data. After substrate
binding to the active site through coordination of
the substrate a-hydoxyl group to the Zn(II) ion,
the Tyr654 (as phenolate) deprotonates the sub-
strate a-OH, triggering Ca-N bond cleavage and
formation of the amidated peptide and glyoxylate.thermal stability of PAL as well as sensitivity to proteolysis (Kol-
hekar et al., 2002).
Earlier studies showed that the physiologic metals for PAL are
Zn2+ and Ca2+ (De et al., 2006). However, these metals can be
removed by chelators such as EDTA or EGTA and subsequent
addition of different divalent metal ions (e.g., Mn2+, Co2+, Ni2+,
Cd2+, and Zn2+) can restore activity (Kolhekar et al., 2002). Inter-
estingly, while the enzyme is inactive with Hg2+, it has enhanced
activity with Cd2+. The structure with Hg2+ at the active site and
substrate was determined; the geometry around Hg2+ is essen-
tially the same as in the native enzyme with Zn2+ and an acetate
ion at the active site (M2+-N3 bonds are larger because of the
bigger size of the Hg2+ ion, but the N3-M2+-N3 angles do not
change significantly). This indicates that the lack of activity of
PAL with Hg2+ depends on the electronic properties of themetal.
Hg2+ is a soft Lewis acid and its strength toward the substrate
OH (a hard Lewis base) is weak and unable to polarize the
O-H bond for catalytic deprotonation. Cd2+ is harder than Hg2+
and exhibits electronic properties more similar to the physiolog-
ical Zn2+.
The lack of activity of PAL with Hg2+ was exploited to prepare
a crystalline complex of PAL with a true substrate, HydHipA. The
structure of this complex unequivocally identified the catalytic
site and the interactions between the substrate and the enzyme.
A model of the complex of PAL with a hydroxylated peptide [Ala-
Ala-Gly(OH)] was generated based on the experimental structure
of PAL-HydHipA. In the PAL-HydHipA structure as well as in the
model, Arg533 anchors the terminal carboxylate of the substrate
and Met784 helps position the carbonyl of the preceding amino
acid.
The most salient feature of the catalytic site, however, is the
presence of two residues, Tyr654 and Arg706, which seem to be
part of a catalytic dyad. Tyr654, in particular, has multiple interac-
tions that are compatible with an important role in catalysis.
Significantly, this residue is absolutely conserved in all PAL
enzymes (Kolhekar et al., 2002) and previously reported experi-
ments showed that replacement of this residue by phenylalanine
results in total loss of enzymatic activity (De et al., 2006). The
substrate a-OH is directly coordinated to the Zn2+ and at the
same time makes an H bond with the OH of Tyr654. Tyr654, in
turn, makes a short H bond with Arg706 and it is at a close
distance from the NH leaving group.
The arrangement of groups in the active site of PAL suggests
amechanism for the lyase reaction (Figure 6). Themost likely first
step is the deprotonation of the substrate’s a-OH group. Coordi-
nation to the Zn2+ must lower significantly the pKa of this
hydroxyl group, favoring the release of the proton. This step
would be enhanced by the presence of a protein base able to
accept the proton. The only group that is in the appropriate loca-
tion to carry out this task is the OH group of Tyr654. For this970 Structure 17, 965–973, July 15, 2009 ª2009 Elsevier Ltd All righgroup to accept the proton, it is necessary that its pKa be low-
ered. The interaction with Arg706 and the proximity to the Zn2+
probably have a significant effect on the pKa of this tyrosine.
We propose that this tyrosine is deprotonated prior to substrate
binding and that the resulting tyrosinate acts as the catalytic
base. For the final bond-breaking step, the tyrosine delivers
the proton to the leaving NH group.
A similar role for a tyrosine has been proposed in the mecha-
nism of 3a-hydroxysteroid dehydrogenase/carbonyl reductase,
in which a lysine residue lowers the pKa of the tyrosine, allowing
it to act as the catalytic base for proton abstraction from the
substrate hydroxyl (Penning et al., 1997; Chang et al., 2007). In
b-lactam synthetase (Miller et al., 2002) and carbapenam synthe-
tase (Miller et al., 2003), homologous enzymes that catalyze the
formation of the four-member b-lactam ring of clavulanic acid
and carbapenems, respectively, a tyrosine has also been
proposed to act as the catalytic base. However, in these cases
a glutamate assists the tyrosine that in turn facilitates deprotona-
tion of the critical a-ammonium ion to initiate the reaction. In PAL,
the proton of the catalytic tyrosine is probably transferred to
solvent before the start of the reaction, allowing the resulting
phenolate to remove the proton from the a-OH, which is also
coordinated to the Zn2+. This tyrosine is positioned to transfer
a proton to the NH of the leaving group. The proximity of the
positive charges of Zn2+ and Arg706 provide a path to lower the
pKa of the tyrosineOH to values compatible with the proposed
mechanism. This arrangement, in which the same tyrosine
residueaccepts aproton from thesubstrate anddonatesaproton
to the leaving group, is particularly attractive because, despite its
simplicity, it is fully compatible with the structural data. The short
distances from the tyrosine OH to the Ca-OH (2.4 A˚) and to the
peptideNH (3.7 A˚) are consistent with the proposed dual func-
tion for this tyrosine. The absence of any other side chains in the
proximity of the scissile bond and the effect on PAL activity of the
mutations of the residues identified as participating in the catal-
ysis argue strongly in favor of this mechanism.
In summary, PAL folds as a six-blade b-propeller with a struc-
tural Ca2+ located in themiddle of the pore and a catalytic Zn2+ at
the active site. We propose a mechanism for the PAL reaction,
validated by site-directed mutagenesis studies. The substrate
binds the enzyme with the a-hydroxyl group directly coordinated
to the Zn2+ and a Tyr654-Arg706 dyad at the active site plays an
essential role in catalysis. The Arg706 lowers the pKa of the
Tyr654, allowing the tyrosine to act as the catalytic base for
hydroxyl deprotonation. The b-propeller structure of PAL and
the proximity of its N and C termini suggest that PHM (the mono-
oxygenase domain of PAM) must be very close to the secretory
granule membrane, where cytochrome b561 provides electron
equivalents via regeneration of ascorbate. Investigations ad-
dressing how PAL interacts with PHM are underway.ts reserved
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Production and Purification of His6-PALcc
A CHO-DG44 cell line secreting His6-PALcc-DGlyc was selected and grown in
CellMax artificial capillary cartridges as described previously (De et al., 2006).
Spent medium was harvested daily and stored frozen after addition of
protease inhibitors. Secreted proteins were concentrated by addition of solid
(NH4)2SO4 to 70% saturation (44.2 g/100 ml). Pellets were washed by suspen-
sion in 20 mM NaTES and 1.5 M (NH4)2SO4 (pH 7.0) (10 ml/pellet from 1 liter)
and centrifuged at 16,000 3 g for 15 min; supernatants were discarded and
pellets were dissolved in 3 mM Tris HCl (pH 8.0) (5 ml/pellet from 1 liter). After
passage through a 0.22 mm syringe filter, samples (from 0.5 liter of spent
medium) were applied to a 5 ml hydrophobic interaction column (HiTrap
phenyl; Pharmacia) equilibrated with 20 mM NaTES and 1.5 M (NH4)2SO4
(pH 7.0) and eluted with a linear gradient to 20 mM NaTES (pH 7.0) over
70 min (flow rate 1.0 ml/min); average recovery to this point was 67%. Frac-
tions enriched in His6-PALcc were pooled based on Coomassie brilliant blue
staining and western blot analysis. After concentration using an Amicon stirred
flow cell with a YM-30 membrane, samples were loaded onto a Superdex
200 gel filtration column (25 3 350 mm) equilibrated with 25 mM NaTES and
100 mM NaCl (pH 7.0). Fractions containing PALcc were identified by SDS-
PAGE, pooled, and concentrated using an Amicon stirred flow cell. Purity
was assessed by Coomassie brilliant blue staining after transfer to polyvinyli-
dene difluoride membranes.
Mutagenesis of PALcc
The Stratagene Quick Change Kit (De et al., 2006) was used with pCI.neo.
signal.His6.PALcc to mutate single amino acids using the following sense
primers (with the corresponding complementary strand) (mutagenic residues
are underlined and italicized): Pal-R533Q, AATAACCTAGTGATTTTCCAC
CAAGGTGACCATGTTTGGGATGGA; Pal-R533A, AATAACCTAGTGATTTTC
CACGCAGGTGACCATGTTTGGGATGGA; Pal-R706Q, GACCAGTTGTGTGT
GGCAGACCAGGAAAATGGCCGAATCCAATGC; Pal-R706A, GACCAGTTGT
GTGTGGCAGACGCGGAAAATGGCCGAATCCAATGC; Pal-M784Q, CCAGT
ACGCAAGCACTTCGACCAGCCTCATGATATTGTGGCTTCT; Pal-M784A, CC
AGTACGCAAGCACTTCGACGCGCCTCATGATATTGTGGCTTCT; Pal-D787A,
AAGCACTTCGACATGCCTCATGCTATTGTGGCTTCTGAAGATGGG.
The resulting pCI.neo vectors were sequenced to ensure accuratemutagen-
esis with no additional changes. The pCI.neo vectors were used for transient
expression in pEAK-Rapid cells. Kinetic analyseswere performedwith 125I-Ac-
Tyr-Val-OH-Gly substrate (1–50 mM) (Kolhekar et al., 2002). Western analyses
of cell extracts and secreted proteins were performed using PAL antibody
JH256 to estimate secretion rates (in all cases, about 2 hr for the cellular
content to be secreted); then westerns were performed with equal PAL activity
to estimate maximal velocity.
PALcc Crystallization, Hg Derivatization, and Preparation
of PALcc Substrate Crystals
Purified PALcc was concentrated to 11 mg/ml in 25 mM NaTES and 100 mM
NaCl (pH 7.0). Crystallization conditions were found by incomplete factorial
screening (solution #37, 0.1 M sodium acetate trihydrate [pH 4.6], 8% w/v
PEG4000; Hampton Research - Crystal Screen HR2-110) using hanging-
drop vapor diffusion at 293 K. Optimization to 0.1 M NaAc (pH 4.6), 9%–
12% PEG8000, yielded better crystals; however, crystals were very small
and most of them did not diffract. New crystallization conditions were found
adding Zn(II) and Fe(III) salts and removing PEG from the original formulation.
In the optimized final condition, the crystallization drop was prepared by mix-
ing 1 ml protein solution and 1 ml mother liquor comprising 0.1 MNaAc (pH 4.8),
0.2 mM ZnAc2, and 0.2 mM FeCl3. A small volume of mother liquor was placed
at the reservoir (0.2 ml instead of the standard 1 ml) to allow slow equilibration
between the drop and mother liquor. Crystals suitable for X-ray diffraction
were grown under these conditions.
A mercury(II) derivative crystal was prepared by soaking PALcc crystals in
mother liquor supplemented with 1 mM mercury(II) acetate for 12 hr.
To prepare stable crystals of PALccwith the nonpeptidic substrate HydHipA
(Aldrich), PALcc was crystallized in 0.1 M NaAc (pH 4.8) and 0.5 mM HgAc2.
PALcc crystals were then soaked in mother liquor supplemented with 5 mM
HydHipA for several hours at 293 K.Structure 17Data Collection, Structure Determination, and Refinement
Crycooling was achieved for all cases by washing the crystals in mother liquor
containing 25% glycerol and flash freezing in liquid nitrogen. An Hg MAD data
to 2.5 A˚ on a mercury-derivative and a Zn MAD data to 2.35 A˚ on a native
crystal were collected at beamline X4A at National Synchrotron Light Source
(Brookhaven National Laboratory); the statistics of data collection are summa-
rized in Tables S1 and S2, respectively. The HKL2000 software package was
Table 2. Statistics for Crystallographic Data Collection and
Refinement
PALcc PALcc-Substratea
Space group P212121 P212121
a (A˚) 52.2 51.9
b (A˚) 75.1 75.1
c (A˚) 97.5 97.0
Data collection
Source X4A APS
Wavelength (A˚) 1.28241 1.00724
Resolution (A˚) 39–2.35 59–2.50
Observed reflections 187,201 90,551
Unique reflections 16,524 13,347
Redundancy 11.3 (7.9) 6.8 (5.7)
Completeness (%) 99.7 (96.9) 99.6 (98.9)
Signal [I/s(I)] 60.9 (4.2) 23.5 (2.7)
Rsym 0.06 (0.49) 0.075 (0.48)
Refinement
Rwork 0.20 0.21
Rfree 0.26 0.26
Stereochemistry
Rms bond lengths (A˚) 0.008 0.008
Rms angles () 1.25 1.25
B factor
Protein 54.7 44.9
Zn 61.7 -
Hg (active site) - 69.8
Ca 49.8 43.0
Fe (contact site) 49.0b -
Hg (contact site) - 62.2b
Acetate 60.0 -
Substratea - 48.7
Glycerol 57.4 -
Water 56.6 43.9
Model composition
Amino acids (atoms) 329 (2,660) 329 (2,660)
Metals 3 3
Acetate 1 (4) -
Substratea - 1 (14)
Glycerol 2 (12) -
Water 149 118
Data collection statistics given in parentheses are for the highest resolu-
tion shell.
a Substrate: HydHipA.
bOccupancy: Fe = 0.7, Hg = 0.35., 965–973, July 15, 2009 ª2009 Elsevier Ltd All rights reserved 971
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Structure of Peptidyl-a(OH)glycine Amidating Lyaseused for data reduction and scaling (Otwinowski and Minor, 1997). One mole-
cule was found per asymetric unit. Three Hg atoms were located per molecule
and initial phases were calculated and refined with the program autoSHARP
(Global Phasing) (Vonrhein et al., 2007), leading to an interpretable electron
density map for most of the structure. However, blades 1 and 2 of the propeller
could not be built using the phases obtained from the Hg MAD experiment.
Then, an anomalous map was prepared with data taken at 1.28 A˚ (Zn edge)
using the initial Hg MAD phases, and the Zn site and a metal contact site
(Fe) were thus accurately located. With those coordinates, very good phases
were calculated and refined using the Zn MAD data by autoSHARP. Density
modification, solvent flattening, and automatic building (25%–30% of the
structure) were carried out in the SHARP pipeline (Vonrhein et al., 2007).
Manual model building was carried out with the program O (Jones et al.,
1991) and refinement was performed with Refmac5 (Murshudov et al., 1997).
Translation, libration, and screw rotation (TLS) anisotropic refinement of rigid
bodies was carried out using each blade as a TLS group (Winn et al., 2003).
Data collection and model statistics are summarized in Table 2.
Diffraction data for the PALcc-HydHipA complex were collected with 1.00 A˚
radiation at SGX-CAT beamline facilities at Sector 31 of the Advanced Photon
Source (Argonne National Laboratory). Data reduction and scaling were
carried out as described above. The initial structure was obtained bymolecular
replacement using the program AMoRe (Navaza, 2001) as implemented in the
CCP4 crystallographic software suite (CCP4, 1994) using the coordinates of
native PALcc as the search model. The program SKETCHER in CCP4 was
used to build the a-hydroxyhippuric acid molecule (HydHipA) and to generate
the library file. The HydHipA was manually placed into the ‘‘extra density’’
using the program O (Jones et al., 1991). Structure refinement was performed
as described above.
Modeling of a PALcc-[Ala-Ala-Gly(OH)] Complex
A model of a (S)-a-hydroxyglycine-extended tripeptide [Ala-Ala-Gly(OH)]
bound to PALcc was built by manual insertion of the tripeptide into the Zn
active site, using the program O (Jones et al., 1991). The tripeptide was care-
fully positioned by matching the atoms of the hydroxyglycine moiety with the
equivalent atoms of the HydHipA, for which experimental data are available.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been submitted to the Protein
Data Bank under ID codes 3FVZ and 3FW0 for PALcc and PALcc substrate,
respectively.
SUPPLEMENTAL DATA
Supplemental data include two figures and two tables and can be found
with this article online at http://www.cell.com/structure/supplemental/
S0969-2126(09)00219-6.
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